Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Mar 15, 2017; 9(3): 98-104
Published online Mar 15, 2017. doi: 10.4251/wjgo.v9.i3.98
Published online Mar 15, 2017. doi: 10.4251/wjgo.v9.i3.98
Score | 0 | 1 | Predicted 5-yr survival |
Nodal status of primary tumor (pN0 vs pN+) | - | + | |
Disease-free interval1 | > 12 mo | < 12 mo | |
Number of tumors | ≤ 1 | > 1 | |
Pre-operative CEA level | ≤ 200 ng/mL | > 200 ng/mL | |
Size of largest tumor | ≤ 5 cm | > 5 cm | |
Score | |||
0 | 60% | ||
1 | 44% | ||
2 | 40% | ||
3 | 20% | ||
4 | 25% | ||
5 | 14% |
- Citation: Veen T, Søreide K. Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis? World J Gastrointest Oncol 2017; 9(3): 98-104
- URL: https://www.wjgnet.com/1948-5204/full/v9/i3/98.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i3.98